Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential regulation of mitochondrial quality control in skeletal muscle by HZE radiation exposure and partial weightbearing in mice.

Life sciences in space research·2026
Same author

The Dual Role of Survival Genes in Neurons and Cancer Cells: a Strategic Clinical Application of DX2 in Neurodegenerative Diseases and Cancer.

Biomolecules & therapeutics·2024
Same author

Contemporary Issue: Health and Safety of Female Wrestlers.

Current sports medicine reports·2024
Same author

Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson's disease treatment.

Journal of translational medicine·2024
Same author

Bi-directional regulation of AIMP2 and its splice variant on PARP-1-dependent neuronal cell death; Therapeutic implication for Parkinson's disease.

Acta neuropathologica communications·2024
Same author

Exercise training modifies the bone and endocrine response to graded reductions in energy availability in skeletally mature female rodents.

Frontiers in endocrinology·2023

Related Experiment Video

Updated: Jun 26, 2026

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Beta-adrenergic blockade and leptin replacement effectively mitigate disuse bone loss.

Kyunghwa Baek1, Susan A Bloomfield

  • 1Department of Health and Kinesiology and Intercollegiate Graduate Faculty of Nutrition, Texas A&M University, College Station, Texas, USA.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|December 31, 2008
PubMed
Summary

Beta-adrenergic blockade significantly mitigates hindlimb unloading-induced bone loss in rats by preserving bone formation and reducing resorption. This effect may involve direct action on bone cells and indirect modulation of leptin levels.

More Related Videos

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Operation Procedure and Precautions of Lingnan Fire-Needle Therapy in Osteoporosis Model Rats
03:56

Operation Procedure and Precautions of Lingnan Fire-Needle Therapy in Osteoporosis Model Rats

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Jun 26, 2026

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Operation Procedure and Precautions of Lingnan Fire-Needle Therapy in Osteoporosis Model Rats
03:56

Operation Procedure and Precautions of Lingnan Fire-Needle Therapy in Osteoporosis Model Rats

Published on: April 26, 2024

Area of Science:

  • Bone Biology
  • Endocrinology
  • Physiology

Background:

  • Hindlimb unloading (HU) causes significant bone loss.
  • Leptin plays a role in bone metabolism.
  • Sympathetic adrenergic signaling may influence bone during disuse.

Purpose of the Study:

  • To investigate the effects of beta-adrenergic blockade on HU-induced bone loss.
  • To examine the impact of beta-adrenergic blockade on serum leptin levels during HU.
  • To compare these effects with leptin replacement therapy.

Main Methods:

  • Adult male rats underwent 28-day hindlimb unloading.
  • Groups received vehicle, leptin analog, or beta-blocker.
  • Bone mineral density (pQCT), bone formation rate, resorption surface, and serum leptin were assessed.

Main Results:

  • Beta-blocker and leptin treatments halved the decrease in cancellous bone mineral density.
  • Bone formation rate was preserved by beta-blocker treatment.
  • Both treatments abolished the HU-induced increase in resorption surface and attenuated the decrease in serum leptin.

Conclusions:

  • Beta-adrenergic blockade mitigates disuse-induced bone loss by stimulating osteoblastic and suppressing osteoclastic activity.
  • The protective effect of beta-blockers may be enhanced by maintaining circulating leptin levels.
  • Peripheral beta-blockade offers a potential therapeutic strategy for disuse osteoporosis.